Cairn Biosciences

SAN FRANCISCO, CA 94110

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $2.86MM
First Award Date 01/01/15
Most Recent Award Date 09/15/16

Key Personnel

Last Name Name Awards Contact
Ludlam Mary J Ludlam 7 Message

5 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/16 - 09/14/18

The Contractor currently provides a high-throughput assay platform that rapidly pinpoints compound mechanism of action and toxicity liabilities through its unique ability to monitor multiple facets of previously inaccessible biology in live cells in real-time. Through this SBIR Phase II contract, the Contractor's existing platform will be appli...

Phase 2 SBIR

Agency: National Science Foundation
Topic: BT
Budget: 08/15/16 - 07/31/18

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is the development of new tools to understand the dynamic behavior of cellular machinery that is disrupted in disease. Unraveling the dynamic aspects of cellular physiology that may be targeted therapeutically requires new technologies capa...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/15/16 - 05/14/17

Toxicological assessments rely on low-throughput, costly animal studies that deliver minimal insights into compound toxicity mechanisms. Induced pluripotent stem cells (iPSCs) are positioned to transform the evaluation of toxic compounds by enabling predictive, physiologically relevant model systems compatible with high throughput screening. Com...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/15/16 - 02/14/17

This project aims to design and develop a multifunctional, reusable and automated microfluidic smart-plate for high throughput, live cell assays. This system will combine a microfluidic multi-well chamber array and an environmental measurement system into a single device, enabling high accuracy and closed-loop control over experiment environment...

Phase 1 SBIR

Agency: National Science Foundation
Topic: BT
Budget: 01/01/15 - 12/31/15

The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project is the development of new tools to study the dynamic behavior of cellular machinery, especially for applications in drug discovery. Unraveling the dynamic aspects of cellular physiology that may be targeted therapeutically requires a new paradigm fo...